Microbial Pattern and Antimicrobial Resistance, a Surgeon’s Perspective: Retrospective Study in Surgical Wards and Seven Intensive-Care Units in Two University Hospitals in Cairo, Egypt
- 1 February 2006
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 212 (Suppl. 1), 8-14
- https://doi.org/10.1159/000089193
Abstract
Significant morbidity and mortality in surgical practice is due to infection with resistant pathogens. Data from Egyptian hospitals may reflect a peculiar pattern. Retrospective study of antimicrobial susceptibility of 1,064 isolates from patients in surgical zones and intensive-care units (ICUs) in the largest 2 hospitals in Cairo in 2003. The infection rate in surgical wards was 0.41%, mostly surgical site infections. Cardiothoracic wards showed higher rates (0.52%). In ICUs, the infection rate was 6.51%, the majority were respiratory. The highest resistance rate was shown by Staphylococcus aureus (23.8%), Pseudomonas (14.9%) and Escherichia coli (10.48%). Enterococci and Citrobacter had rates below 1%. Pseudomonas aeruginosa had the highest resistance rate with third-generation cephalosporins (Cef3) and the lowest with imipenem, while for Enterobacter and Klebsiella it was highest with Cef3 and lowest with imipenem. E. coli showed the highest rate with quinolone 2 and Cef3, but there was no resistance to imipenem. Acinetobacter demonstrated the highest resistance rate with quinolone 2 and the lowest with fourth-generation cephalosporins (Cef4), while for methicillin-resistant S. aureus it was 60%. All enterococci were sensitive to vancomycin. The study provides meaningful data on a high antimicrobial resistance in Egypt. Failure of hospital hygiene and overuse of antibiotics are considered responsible.Keywords
This publication has 25 references indexed in Scilit:
- Pseudomonas aeruginosaBloodstream Infection: Importance of Appropriate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2005
- Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002Antimicrobial Agents and Chemotherapy, 2004
- Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000Journal of Antimicrobial Chemotherapy, 2004
- Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001Antimicrobial Agents and Chemotherapy, 2003
- Infection Control in the ICUChest, 2001
- Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study Commentary: antibiotic resistance is a dynamic processBMJ, 2001
- Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosaClinical Infectious Diseases, 1999
- Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in HospitalsClinical Infectious Diseases, 1997
- Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogensDiagnostic Microbiology and Infectious Disease, 1996
- Epidemiology of candidiasisJournal of Hospital Infection, 1995